Adenosine receptors as potential therapeutic targets
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 4 (12) , 542-551
- https://doi.org/10.1016/s1359-6446(99)01421-x
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Effect of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by simultaneous GABAB and adenosine receptor activationNeuroscience Letters, 1998
- Theophylline-induced recovery in a hemidiaphragm paralyzed by hemisection in rats: Contribution of adenosine receptorsNeuropharmacology, 1998
- Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gαs-linked) ReceptorsThe Journal of Experimental Medicine, 1997
- Adenosine A2A Receptors and NeuroprotectionAnnals of the New York Academy of Sciences, 1997
- SCH 58261: A selective A2A adenosine receptor antagonistsDrug Development Research, 1997
- Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 bindingBritish Journal of Pharmacology, 1997
- Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic ratsNeuroscience Letters, 1997
- Renal adenosine A1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the ratBritish Journal of Pharmacology, 1997
- P1-purinoceptor-mediated vasodilatation and vasoconstriction in hypoxiaJournal of Autonomic Pharmacology, 1996
- Adenosine in treating cardiac arrhythmiasJournal of Autonomic Pharmacology, 1996